185 related articles for article (PubMed ID: 30482161)
1. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.
Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH
BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161
[TBL] [Abstract][Full Text] [Related]
2. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
Yang HY; Wu DA; Chen MC; Hsu BG
Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
[TBL] [Abstract][Full Text] [Related]
3. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
[TBL] [Abstract][Full Text] [Related]
4. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.
Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016
[TBL] [Abstract][Full Text] [Related]
5. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.
Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A
Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin is a predictor for central arterial stiffness in hypertensive patients.
Tsai JP; Hsu BG; Lee CJ; Hsieh YH; Chen YC; Wang JH
Nephrology (Carlton); 2017 Oct; 22(10):783-789. PubMed ID: 27450396
[TBL] [Abstract][Full Text] [Related]
7. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
[TBL] [Abstract][Full Text] [Related]
8. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania.
Gaudio A; Fiore V; Rapisarda R; Sidoti MH; Xourafa A; Catalano A; Tringali G; Zanoli L; Signorelli SS; Fiore CE
Mol Med Rep; 2017 May; 15(5):3420-3424. PubMed ID: 28339088
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5.
Lu JW; Chi PJ; Lin YL; Wang CH; Hsu BG
Adipocyte; 2020 Dec; 9(1):206-211. PubMed ID: 32403968
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
[TBL] [Abstract][Full Text] [Related]
12. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
[TBL] [Abstract][Full Text] [Related]
13. Association of serum leptin levels with central arterial stiffness in coronary artery disease patients.
Tsai JP; Wang JH; Chen ML; Yang CF; Chen YC; Hsu BG
BMC Cardiovasc Disord; 2016 May; 16():80. PubMed ID: 27151106
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Cohort Study of the Association between Serum Osteopontin Levels and Aortic Stiffness in Hypertensive Patients.
Chang YC; Tsai JP; Wang JH; Hsu BG
Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010737
[TBL] [Abstract][Full Text] [Related]
15. Serum Mimecan Is Associated With Arterial Stiffness in Hypertensive Patients.
Gu X; Zhao L; Zhu J; Gu H; Li H; Wang L; Xu W; Chen J
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26206738
[TBL] [Abstract][Full Text] [Related]
16. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
[TBL] [Abstract][Full Text] [Related]
17. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
[TBL] [Abstract][Full Text] [Related]
18. Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.
Jin S; Zhu M; Yan J; Fang Y; Lu R; Zhang W; Zhang Q; Lu J; Qi C; Shao X; Zhang H; Jiang R; Ni Z
Biomark Med; 2016 Jul; 10(7):689-99. PubMed ID: 27347702
[TBL] [Abstract][Full Text] [Related]
19. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension.
Ma WH; Wang XL; Du YM; Wang YB; Zhang Y; Wei DE; Guo LL; Bu PL
BMC Cardiovasc Disord; 2012 May; 12():35. PubMed ID: 22642467
[TBL] [Abstract][Full Text] [Related]
20. Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.
Hou JS; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG; Tsai JP
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
